NCT02969109View on ClinicalTrials.gov

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

417

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 18, 2018

Study Completion Date

September 18, 2018

Conditions
Non-muscle Invasive Bladder Cancer
Trial Locations (1)

55455

Institute for Prostate and Urologic Cancers - University of Minnesota, Minneapolis

Sponsors
All Listed Sponsors
lead

Genomic Health®, Inc.

INDUSTRY

NCT02969109 - Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter